The emerging approach of tirzepatide peptide represents a significant development in the care of type 2 diabetes. Different to existing drugs, tirzepatide impacts multiple pathways – glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) – leading to enhanced glucose regulation and anticipated weight reduction. E